UCSD Microrobots Propel Lung Cancer Survival Rates: Discover How Mice Survival Improved to 37 Days
Tejal Somvanshi
Tejal Somvanshi
UCSD engineers have developed microrobots that enhance lung cancer survival rates in mice, extending lifespan significantly.
Photo Source - Google
These tiny robots swim through the lungs, delivering cancer drugs directly to metastatic tumors, a breakthrough in medical nanotechnology.
Photo Source - Google
The study, led by professors Wang and Zhang, achieved a median survival improvement to 37 days in treated mice.
Photo Source - Google
The microrobots are ingeniously crafted with drug-filled nanoparticles attached to green algae cells, enabling efficient drug delivery.
Photo Source - Google
Nanoparticles are coated with biodegradable polymer spheres loaded with doxorubicin and red blood cell membranes for immune evasion.
Photo Source - Google
This formulation ensures safe and effective treatment, with biocompatible materials used throughout.
Photo Source - Google
Previous trials demonstrated the microrobots' efficacy against lethal pneumonia, now adapted to combat lung cancer metastases.
Photo Source - Google
The active swimming motion of these microrobots enhances drug distribution and prolongs retention in deep lung tissues.
Photo Source - Google
UCSD researchers aim to advance to larger animal trials and, ultimately, clinical trials for human lung cancer treatment.
Photo Source - Google
More Stories
Learn more